Physician’s Odyssey

#2073 to Fei Rui tree rival

The news of Kreisman’s private meeting with Joanna soon reached Robinson’s ears, who was eating breakfast. His eyes showed anger, and he roared in a low voice, “Really a double-faced guy.”

The assistant knew that Robinson was in a bad mood, so he sat aside wittily.

Robinson felt that the bread was difficult to eat, and the black tea in the cup was drunk clean. He got up and went to the self-service tea bar. Just after receiving the tea, he saw an acquaintance.

"It's nice to meet you." Joshua greeted him more cordially than expected.

"Oh, it turned out to be you." Robinson pretended to be surprised. In fact, he saw Joshua at the press conference yesterday.

Joshua is his old colleague, strictly speaking his old boss, the former vice president of Ferry Pharmaceuticals. It is because of him that Robinson can successfully take the post.

There are many versions of Joshua’s departure from Ferry Pharmaceuticals, the most credible of which is that Joshua was shamed by Robinson.

The news about Joshua's private contact with several small pharmaceutical companies was told by Robinson to the senior management of the group, so that he lost trust in Joshua.

After Joshua was fired, she heard that she started her own business and did a good job.But in Robinson's eyes, he is an out-and-out loser.

"What? Are you planning to fight for Sanwei Bio's innovative medicine?" When Robinson said this, he was a little arrogant. Although the other party is his old boss, he is now the core senior of Ferry Pharmaceuticals, and Joshua is just The boss of a start-up pharmaceutical company.

If Robinson used the resources in his hand to impose a blockade on Joshua, due to Ferry's face, major hospitals would definitely boycott Joshua's current products, and he could immediately become a prototype.

The reason why he didn't do this was because Robinson never regarded Joshua as an opponent and felt that there was no need to spend too much energy on him.

Joshua knew well to his veterans that although he was very young, he had a bad stomach, and Ferry Pharmaceuticals had merged and made enemies everywhere in the past two years. The reason was that Robinson secretly planned.

On the surface, Ferry Pharmaceuticals is showing a prosperous momentum, but there are huge hidden dangers behind this glamour.

Qiao Shuya smiled slightly: "No way, my business has just started. I will definitely fight for opportunities when I encounter opportunities."

Robinson was very satisfied with Joshua’s attitude. He shrugged and said, “It’s not bad to treat this experience as an opportunity to accumulate contacts. Maybe it will succeed next time."

"Yeah, I think so too." Joshua said with a big smile.

Robinson was very happy. When he used to be Joshua’s subordinates, he always behaved respectfully. Now that Feng Shui turns around, it is Joshua’s turn to lower his eyebrows.

"Go back and sit down when you have time. I have a few small orders over there, which can be handed over to you." Robinson smiled easily.

"Okay, I also miss the life of Ferry Pharmaceuticals, and when I have time, I will definitely visit." Joshua said with a smile.

When Robinson left with the black tea, Joshua's eyes showed a gleam. Of course he couldn't understand Robinson's arrogant look, but he also knew that he had to bow his head when he should bow.

Not long after Joshua sat down, an Eastern face sat directly opposite him, and Joshua was a little surprised.

The opposite man smiled and said in fluent English: "My name is Chen Hao and I am Mr. Yan Peng's assistant."

Joshua's eyes showed surprise, "Hello, nice to meet you, I wonder what's the matter?"

"Mr. Yan Peng asked me to remind you that you have a good chance to obtain the patent rights of two innovative drugs of our company. Please also prepare enough funds, especially the advance payment must be in place in time." Chen Hao said with a smile.

Joshua was dazzled by the huge surprise and looked at Chen Hao in surprise, thinking that he was dreaming. He originally thought that he had gained nothing from this trip to LD, because there were so many strong opponents and his company was too humble. .

"Thank you for the good news, but I still can't believe this fact." Joshua said with a wry smile, but reason told himself that it was true, because no one would make such a meaningless joke with himself.

"It seems that you underestimated your own strength. You used to be the vice president of Ferry Pharmaceuticals. This is enough to make us admire." Chen Hao explained patiently, "I believe you will have many ways to make innovative drugs play a role. The greatest value."

Joshua nodded heavily: "When can I sign the contract?"

"It is expected that the list of winning bidders will be announced within these two days. At the same time as signing the contract, you also need to credit the advance payment to our account in time, so Mr. Yan will notify you in advance." Chen Hao explained patiently.

Joshua hurriedly said: "I will arrange this now."

...

Sanwei Biomedicine also has four innovative drugs. The ownership is determined by bidding, attracting a large number of well-known pharmaceutical companies from around the world, including top pharmaceutical giants such as Elber Pharmaceuticals, Ferrer Pharmaceuticals, and Noy Pharmaceuticals .The market for virus-oriented innovative drugs is huge. As long as it is handed over to any pharmaceutical giant, it can easily create a market size of 5 billion US dollars. If it is handed over to an ordinary pharmaceutical company, this lucky pharmaceutical company can also be shaped into a second-tier level. Pharmaceutical Group.

Sanwei Biomedical needs to comprehensively consider the comprehensive strength of the bidder, not only the strength of the current stage, the key is the potential of the team.

Although handing innovative drugs to companies that have matured channels, markets, and operations can save a bit of worry, and the rebate sharing will be stable, Su Tao believes that we should focus on late-stage emerging talents.

There are many reasons. First, although a large group like Tosca has rich experience and complete channels, it has low work efficiency and heavy staff inertia. Although the sales scale agreed in the contract can be completed through the system, it is not as good as The new enterprise is so aggressive.

Second, Su Tao wants to create a myth, "An incompetent company, relying on the innovative drugs of Sanwei Pharmaceutical and Biology, has completed its transformation and directly enters the second-rate pharmaceutical company sequence." This will be a convincing advertisement.The innovative and generic drugs of Sanwei Biomedicine are not worried about their sales.

Third, profit is one aspect. Su Tao hopes that innovative drugs can change the world medical landscape. This time, ten innovative drugs are based on traditional Chinese medicines. The next innovative drug may be proprietary Chinese medicines. Su Tao needs new medicines. The power of China to break the current situation, if relying on the four major pharmaceutical groups, I am afraid it will be difficult to achieve results, because they are old forces and they will definitely have reservations when it comes to core interests.

Noy Group took the initiative to bow its head with Tosca Group this time. In fact, it smelled the danger, because the main products they depend on for survival are antiviral drugs. If a new generation of antiviral drugs goes online, Noy Group’s products Will gradually be replaced, the biggest profit growth point disappears, and operations will fall into a passive situation.

The Noy Group knows that this is a change that cannot be lost, so it racked its brains to try to delay its own decline. If it can be two or three innovative drugs, it will give itself a chance to breathe.

Su Tao holds the list of bidders sent by Zhao Jian in his hand. The first ones are Noy Group and Ferry Group. Zhao Jian said: “Noy Group has the highest score in the channel construction of antiviral drugs. After all, they The same type of products previously operated accounted for more than 50% of the global share. If new drugs are handed over to them, they will be able to complete the replacement within a month, and there is no need to worry about drug price increases and consumer sensitivity."

Su Tao nodded slightly, "What did Yan Peng say?"

Zhao Jiandao: "Yan Peng believes that it cannot be handed over to Noy Pharmaceuticals if it is handed over to any pharmaceutical company."

"The reason?" Su Tao asked blankly.

"He believes that after Noy Pharma has obtained the patents for innovative drugs, it is very likely to delay the time for new drugs to be put on the shelves, because large pharmaceutical companies like Noy have factories all over the world, and their annual purchases will be advanced, and the raw materials have already been scheduled. Well, if new drugs are put on the shelves quickly, it will cause huge damage to the original plan." Zhao Jian slowly said.

"You now know why I chose Yan Peng as your partner?" Su Tao finally had a smile on his face.

Zhao Jian nodded and said, "Lao Yan is indeed very old in terms of operations, and he is a scheming guy."

Su Tao smiled and said: "One righteous and one evil can complement each other. For so many years, Lao Yan Zongheng Mall, he is much better than you in terms of experience and actual combat level, so you have to learn from him in many cases."

Zhao Jian frowned and said, "If you don't give Neue Group a chance, should you give Ferry Group a chance?"

The six innovative drugs transferred to Tosca will be jointly sold by Tosca and Elber. Therefore, the two pharmaceutical companies have already withdrawn from the competition, and Noy and Ferry have the highest voices, but Ferry Group’s reputation Everybody knows.

"Nor give the Ferry Group a chance." Su Tao pointed to the list of the third position, and said with a smile, "Lao Yan knows what I think, so although he chose a company in the third list, although it is not particularly famous, it has recently A medium-sized pharmaceutical company with very stable operating conditions in the year.

This is a pharmaceutical company from Canada. The founder once held an important position at Ferry Pharmaceuticals. After resigning his position, he started his own business in Canada. Relying on his acumen to products, he completed the accumulation of wealth in ten years. Listed on the New York Stock Exchange, the stock price has been rising."

Zhao Jian frowned and said, "Are you planning to make enemies for Ferry Pharmaceuticals?"

Su Tao said with a smile: "Who said no?"

Zhao Jiandao: "But with the financial strength of this company, you can get at most two patents. How to deal with the other two patents?"

"Give it to No. 4 and No. 5 on the list. Now that we have decided to use these ten innovative drugs to change the world's pharmaceutical landscape, we have to break the boat and be thorough." Su Tao's eyes flashed.